4.8 Article

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Journal

SCIENCE
Volume 324, Issue 5924, Pages 246-251

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1171491

Keywords

-

Funding

  1. NIH [AI-058113]
  2. predoctoral fellowship from the Achievement Rewards for College Scientists Foundation
  3. Skaggs Institute
  4. NIH National Institute of General Medical Sciences (NIGMS) [U54 GM074898, Y1-GM-1104]
  5. National Cancer Institute [Y1-CO-1020]
  6. U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]

Ask authors/readers for more resources

Influenza virus presents an important and persistent threat to public health worldwide, and current vaccines provide immunity to viral isolates similar to the vaccine strain. High-affinity antibodies against a conserved epitope could provide immunity to the diverse influenza subtypes and protection against future pandemic viruses. Cocrystal structures were determined at 2.2 and 2.7 angstrom resolutions for broadly neutralizing human antibody CR6261 Fab in complexes with the major surface antigen (hemagglutinin, HA) from viruses responsible for the 1918 H1N1 influenza pandemic and a recent lethal case of H5N1 avian influenza. In contrast to other structurally characterized influenza antibodies, CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of HA1 and HA2. The antibody neutralizes the virus by blocking conformational rearrangements associated with membrane fusion. The CR6261 epitope identified here should accelerate the design and implementation of improved vaccines that can elicit CR6261-like antibodies, as well as antibody-based therapies for the treatment of influenza.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available